Raymond James & Associates’s Nuvation Bio NUVB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-14,710
| Closed | -$19.7K | – | 3847 |
|
|
2023
Q3 | $19.7K | Sell |
14,710
-3,000
| -17% | -$4.02K | ﹤0.01% | 3700 |
|
|
2023
Q2 | $31.9K | Sell |
17,710
-3,900
| -18% | -$7.02K | ﹤0.01% | 3687 |
|
|
2023
Q1 | $35.9K | Buy |
21,610
+600
| +3% | +$996 | ﹤0.01% | 3714 |
|
|
2022
Q4 | $40.3K | Sell |
21,010
-350
| -2% | -$672 | ﹤0.01% | 3675 |
|
|
2022
Q3 | $48K | Hold |
21,360
| – | – | ﹤0.01% | 3662 |
|
|
2022
Q2 | $69K | Buy |
21,360
+5,300
| +33% | +$17.1K | ﹤0.01% | 3700 |
|
|
2022
Q1 | $84K | Buy |
16,060
+3,600
| +29% | +$18.8K | ﹤0.01% | 3794 |
|
|
2021
Q4 | $106K | Buy |
12,460
+1,000
| +9% | +$8.51K | ﹤0.01% | 3806 |
|
|
2021
Q3 | $114K | Buy |
11,460
+500
| +5% | +$4.97K | ﹤0.01% | 3769 |
|
|
2021
Q2 | $102K | Buy |
+10,960
| New | +$102K | ﹤0.01% | 3780 |
|